Central Sensitisation: The Science That Explains Fibromyalgia Pain | ALIV

One of the most validating things a fibromyalgia patient can hear from a clinician is: "Your pain is real, your nervous system has genuinely changed, and there is a well-understood biological mechanism that explains exactly what you are experiencing." Central sensitisation is that mechanism — and understanding it not only validates the experience of fibromyalgia but points directly toward the interventions that address it at its biological root.

What Central Sensitisation Means

The nervous system processes pain through a two-stage system: peripheral nociceptors (pain receptors in the body's tissues) detect potentially damaging stimuli and send signals via the spinal cord to the brain, where the brain interprets those signals and generates the conscious experience of pain. In this normal system, the brain has powerful descending inhibitory pathways — essentially a volume control — that can modulate how much of the peripheral signal gets amplified into conscious pain experience. These inhibitory pathways prevent every minor physical stimulus from becoming overwhelming pain.

In central sensitisation, the gain on this system is permanently turned up. The amplification is increased (more pain from the same peripheral signal); the inhibitory pathways are weakened (less modulation from above); and the threshold for activation is lowered (smaller stimuli trigger the system). The result is: pain from stimuli that would not normally be painful (allodynia — light touch feels painful); exaggerated pain from stimuli that would normally be mildly painful (hyperalgesia); pain that persists long after any peripheral stimulus has resolved; and pain that spreads beyond the initial area of stimulus.

This is not a metaphor or a description of psychological pain amplification — it is a measurable physiological state. Levels of substance P (a pain neurotransmitter) in the cerebrospinal fluid of fibromyalgia patients are consistently three times higher than in healthy controls. Functional MRI studies show amplified activation in pain-processing brain regions (insular cortex, anterior cingulate cortex, thalamus) in fibromyalgia patients relative to healthy controls in response to identical stimuli. The neuroscience of central sensitisation is established — it explains the clinical features of fibromyalgia with precision. See the full diagnostic context: what fibromyalgia is and why it takes so long to diagnose.

What Drives Central Sensitisation in Fibromyalgia

Central sensitisation in fibromyalgia appears to be driven and maintained by several interacting factors: disrupted sleep (which removes the brain's daily reset of pain modulation); chronic psychological stress (which keeps the HPA axis and sympathetic nervous system in a state of hyperarousal that maintains sensitisation); nutritional deficiencies (particularly magnesium, which is a natural NMDA receptor antagonist — the NMDA receptor is the primary molecular driver of central sensitisation); prior acute pain experiences that have left the nervous system in a sensitised state; and in some patients, autoimmune or inflammatory processes that generate peripheral nociceptive input sustaining the central state.

NMDA (N-methyl-D-aspartate) receptors in the spinal cord dorsal horn are the key molecular mediators of central sensitisation — they are "wind-up" receptors that amplify repeated nociceptive input into sustained sensitisation. Magnesium physiologically blocks the NMDA receptor at rest — a deficiency of magnesium removes this natural inhibitory brake and facilitates sensitisation. This is the mechanistic explanation for why magnesium deficiency worsens fibromyalgia and why magnesium supplementation and IV magnesium have demonstrated benefit in pain management. Read: magnesium deficiency and chronic pain.

What Addresses Central Sensitisation

Approaches that genuinely modulate central sensitisation include: sleep improvement (restoring the brain's overnight pain inhibitory reset); graded aerobic exercise (which activates endogenous opioid and serotonin systems that support descending pain inhibition); cognitive approaches including mindfulness and pain catastrophising reduction (which engage the prefrontal cortex's modulation of the limbic-pain system interface); medications that target the central serotonin-norepinephrine system (duloxetine, milnacipran) which strengthen descending inhibitory pathways; and nutritional interventions that remove the biochemical drivers of sensitisation — particularly magnesium and vitamin B complex. ALIV's Fibromyalgia Relief IV addresses the nutritional and antioxidant component of this picture.

Is central sensitisation permanent?

No — central sensitisation is a neuroplastic state, which means it can change. The brain that learned to amplify pain can, with appropriate intervention, reduce that amplification. The clinical evidence for this is observed in patients who achieve sustained improvement in fibromyalgia with comprehensive management — the pain thresholds measurably improve, the allodynia reduces, and the functional MRI patterns of brain activation shift toward more normal patterns over time. The process is slow and requires sustained, consistent intervention — but the nervous system's plasticity makes genuine improvement biologically possible.

Can stress alone cause central sensitisation?

Chronic psychological stress is one of the most potent drivers and maintainers of central sensitisation. The HPA axis stress response keeps the nervous system in sympathetic hyperarousal — which is mechanistically incompatible with the parasympathetic state required for effective descending pain inhibition. Many fibromyalgia patients report that their worst pain periods coincide with the highest life stress periods — this is not coincidence, it is the clinical expression of stress-maintained central sensitisation. Stress reduction is therefore a genuine pain management intervention in fibromyalgia, not a dismissive suggestion.

Why does fibromyalgia pain move around?

The migratory, shifting quality of fibromyalgia pain is a characteristic feature of central sensitisation — the amplified nervous system generates pain that is not anchored to a single peripheral pathology. Because the sensitisation is widespread throughout the central processing system, any area of the body can become the focus of the amplified pain experience at any given time. Weather changes, sleep disruption, emotional stress, and physical exertion can all shift which area is most prominent. This is in contrast to joint pathology, where pain is consistently localised to the affected structure.

Does fibromyalgia pain change in the monsoon?

Many fibromyalgia patients in Pune and Mumbai report significant symptom worsening during the monsoon season and winter months. The mechanisms are multiple: barometric pressure changes affect nociceptor sensitivity in tissues; cold temperature reduces peripheral blood flow and increases muscle tension, which can trigger pain; and the reduction in sunlight reduces vitamin D synthesis and serotonin production — both relevant to central sensitisation. These weather-related flares are genuine physiological phenomena, not imagined. Managing the nutritional drivers (vitamin D, magnesium) and sleep during high-risk seasonal periods is a practical clinical approach.